Concepedia

D. Roychowdhury

DR

Statistics

Publications

16

Citations

2.8K

H-Index

13

Active since

1974

Affiliations

Rashtrasant Tukadoji Maharaj Nagpur University(Current)

Eli Lilly (United States)

National Institute for Research in Reproductive Health

Aarhus University Hospital

D. Roychowdhury is an author at Rashtrasant Tukadoji Maharaj Nagpur University specializing in medicine, pharmacology, and oncology.

Publications per year

1974–2023

16

Publications

16

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study

Hans von der Maase, Steen Werner Hansen, J.T. Roberts et al. · Journal of Clinical Oncology · 2000 · 2.3K citations · Full text

, , +11

Health-Related Quality-of-Life Parameters as Independent Prognostic Factors in Advanced or Metastatic Bladder Cancer

D. Roychowdhury, A. Hayden, Astra M. Liepa · Journal of Clinical Oncology · 2003 · 120 citations

, , +17

First-line gemcitabine versus epirubicin in postmenopausal women aged 60 or older with metastatic breast cancer: a multicenter, randomized, phase III study

Olavo Feher, P Vodvářka, Jacek Jassem et al. · Annals of Oncology · 2005 · 93 citations

, , +12

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study

Hans von der Maase, Steen Werner Hansen, J.T. Roberts et al. · Journal of Clinical Oncology · 2023 · 44 citations · Full text

, , +11

Results of an analysis of cardiac function in 2,812 patients treated with lapatinib

EA Perez, Julie Byrne, Isaac W. Hammond et al. · Journal of Clinical Oncology · 2006 · 40 citations

, , +17

1–5 of 16